首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1451616

2024-2032 年按產品、年齡層、配銷通路和地區分類的避孕藥物市場報告

Contraceptive Drugs Market Report by Product, Age Group, Distribution Channel, and Region 2024-2032

出版日期: 2024年03月02日 | 出版商:

IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球避孕藥市場規模達到158億美元。展望未來， IMARC Group預計到2032年市場規模將達到245億美元，2024-2032年複合年成長率（CAGR）為4.9%。

避孕藥是指用於預防懷孕、控制生育率的避孕藥物。它們是使用兩種雌激素（即雌激素和黃體素）合成配製而成，可防止排卵。這些荷爾蒙也會使子宮頸黏液變稠或改變子宮內膜，以阻止精子進入子宮頸進行受精和植入。避孕藥有助於降低痤瘡、骨質疏鬆、卵巢癌、輸卵管和子宮感染以及經前症候群 (PMS) 的風險。因此，醫療保健從業人員會使用這些藥物來抑制育齡婦女意外懷孕。目前，它們主要有口服、注射和外用製劑。

避孕藥市場趨勢：

推動全球避孕藥市場的關鍵因素之一是消費者對計劃生育意識的提高、人口的增加以及意外懷孕事件的增加。與此一致的是，由於現代避孕方法具有多種好處，包括最佳的安全性和更好的臨床結果，醫療保健從業人員對現代避孕方法的傾向轉變為傳統避孕方法的另一個促進因素。此外，食品藥物管理局（FDA）等多個監管機構經常批准新藥，也支持了市場的成長。此外，明膠膠囊和非荷爾蒙陰道凝膠的出現，透過維持陰道 pH 水平，為精子創造了一個不適合生存的環境，這也推動了市場的成長。除此之外，持續的研發（R＆D）活動以及非政府組織（NGO）和衛生機構為提高消費者對避孕技術、婦女健康和性健康的認知而採取的有利舉措，正在積極促進市場成長。

本報告回答的關鍵問題

2023年全球避孕藥市場規模有多大？
2024-2032年全球避孕藥市場的預期成長率是多少？
推動全球避孕藥市場的關鍵因素是什麼？
COVID-19 對全球避孕藥市場有何影響？
基於該產品的全球避孕藥市場的詳細情形如何？
全球避孕藥市場依年齡層分類情況如何？
全球避孕藥市場的配銷通路分類如何？
全球避孕藥市場的重點區域有哪些？
全球避孕藥市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- AbbVie Inc.
- Afaxys Inc.
- Agile Therapeutics
- Amneal Pharmaceuticals Inc.
- Bayer AG
- Johnson & Johnson
- Mithra Pharmaceuticals SA
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.

簡介目錄圖表

Product Code: SR112024A6300

The global contraceptive drugs market size reached US$ 15.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.

Contraceptive drugs refer to birth control medications that are used to prevent pregnancy and control the birth rate. They are synthetically formulated using two female hormones, namely estrogen and progestin, which prevent ovulation. These hormones also thicken cervical mucus or alter the womb lining to prohibit the entrance of sperm into the cervix for fertilization and implantation. Contraceptive drugs assist in lowering the risks of acne, bone thinning, ovarian cancer, infections in the fallopian tubes and uterus, and premenstrual syndrome (PMS). As a result, they are administered by healthcare practitioners to inhibit unwanted pregnancy amongst women of childbearing age. At present, they are mainly available in oral, injectable, and topical formulations.

Contraceptive Drugs Market Trends:

One of the key factors driving the global contraceptive drugs market is the rising consumer consciousness regarding family planning, the increasing population, and the rising instances of unintended pregnancies. In line with this, the shifting inclination of healthcare practitioners toward modern contraceptive methods over conventional procedures, owing to their multiple benefits, including optimal safety, and better clinical outcomes, are acting as another growth-inducing factor. Additionally, the frequent approvals of novel medications by several regulatory bodies, such as the food and drug administration (FDA), are supporting the market growth. Moreover, the advent of gelatin capsules and non-hormonal vaginal gels that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is impelling the market growth. Apart from this, continuous research and development (R&D) activities and the favorable initiatives undertaken by non-governmental organizations (NGOs) and health agencies to sensitize consumers about contraception techniques, women's health, and sexual wellness are positively augmenting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, age group and distribution channel.

Breakup by Product:

Oral Contraceptive Pills

Injectable Contraceptives

Topical Contraceptives

Breakup by Age Group:

15-24 years

25-34 years

35-44 years

Above 44 years

Breakup by Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

Clinics

Online Channel

Public Channel and NGOs

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Questions Answered in This Report

1. What was the size of the global contraceptive drugs market in 2023?
2. What is the expected growth rate of the global contraceptive drugs market during 2024-2032?
3. What are the key factors driving the global contraceptive drugs market?
4. What has been the impact of COVID-19 on the global contraceptive drugs market?
5. What is the breakup of the global contraceptive drugs market based on the product?
6. What is the breakup of the global contraceptive drugs market based on the age group?
7. What is the breakup of the global contraceptive drugs market based on the distribution channel?
8. What are the key regions in the global contraceptive drugs market?
9. Who are the key players/companies in the global contraceptive drugs market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Oral Contraceptive Pills
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Injectable Contraceptives
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Topical Contraceptives
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Age Group

7.1 15-24 years
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 25-34 years
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 35-44 years
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Above 44 years
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Retail Pharmacy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Hospital Pharmacy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Online Channel
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Public Channel and NGOs
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Afaxys Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Agile Therapeutics
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Amneal Pharmaceuticals Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Bayer AG
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Johnson & Johnson
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Mithra Pharmaceuticals SA
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Novartis AG
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Teva Pharmaceutical Industries Ltd.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Viatris Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2023
Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2023
Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Contraceptive Drugs (15-24 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Contraceptive Drugs (15-24 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Contraceptive Drugs (25-34 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Contraceptive Drugs (25-34 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Contraceptive Drugs (35-44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Contraceptive Drugs (35-44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2023
Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Contraceptive Drugs Market: Competitive Structure
Table 7: Global: Contraceptive Drugs Market: Key Players

02-2729-4219

+886-2-2729-4219